Cross-sectional study of antimicrobial use and treatment decision for preweaning Canadian dairy calves

• Published in: JDS communications 2022-01, Vol.3 (1), p.72-77
• Main Authors: Uyama, Tamaki, Kelton, David F., Morrison, Emma I., de Jong, Ellen, McCubbin, Kayley D., Barkema, Herman W., Dufour, Simon, Sanchez, Javier, Heider, Luke C., LeBlanc, Stephen J., Winder, Charlotte B., McClure, J.T., Renaud, David L.
• Format: Article
• Language: English
• ISSN: 2666-9102; 2666-9102
• DOI: 10.3168/jdsc.2021-0161

[Display omitted] •More than half of producers used multiple signs when treating calf pneumonia.•More than half of producers included systemic signs when treating calf diarrhea.•Farmers with a treatment protocol used multiple signs for antimicrobial use (bovine respiratory disease).•Farmers with a treatment protocol used systemic signs for antimicrobial use (scours). Antimicrobials should be used prudently in farm animals to prevent the development of resistant bacteria in both humans and animals. The objective of this study was to investigate Canadian dairy producers' practices for antimicrobial use in the treatment of disease in preweaning dairy calves. In-person questionnaires were administered to 144 dairy producers across 5 provinces in Canada between July 2019 and August 2020. Almost all (96%) producers used antimicrobials to treat calves with respiratory disease, but only 27% indicated they had a written treatment protocol for respiratory disease. Most (95%) of these protocols for respiratory disease were developed with input from the herd veterinarian. Seventy-four percent of producers used antimicrobials to treat calf diarrhea, with 37% of producers having a written treatment protocol for calf diarrhea with input from the herd veterinarian. The combinations of signs adopted by the producers for antimicrobial treatment in calf respiratory disease and diarrhea were evaluated based on findings from other studies. More than half (56%) of producers who used antimicrobials for calf respiratory disease decided to use antimicrobials by evaluating multiple clinical signs. Eighty-two percent of producers who used antimicrobials for calf diarrhea made decisions based on systemic signs of disease, presence of bloody stool, no response to previous treatment, or on the recommendation from the herd veterinarian. Producers with a written treatment protocol had 3 to 7 times greater odds of using antimicrobials based on multiple signs or systemic signs of disease compared with those without a protocol. Further research may investigate other calf management practices related to decision-making by producers in using antimicrobials to improve antimicrobial stewardship on dairy farms.